|
Day I: Sunday : January 23, 2005 |
| 08.00
– 08.45 hrs
|
|
Registration |
| 08.45 – 09.00
hrs
|
|
Inauguration |
| 09.00 – 10.00
hrs
|
|
Introductory remarks
Inaugural Address
Mr.
Pankaj R. Patel, Chairman & Managing Director,
Zydus Cadila
Chief-Guest |
| 10.00
- 10.30 hrs
|
|
Tea Break |
| 10.30
- 11.30 hrs
|
Key-Note
Address
(PL-1)
|
"Gene
Therapy: Ups and Downs"
Prof. Inder M. Verma
Professor, Laboratory of Genetics,
The Salk Institute, La Jolla,
California, USA |
| 11.30 - 12.15
hrs
|
Invited
Lecture
(IL – 1)
|
"From Genome to Therapy"
Dr. Dalia
Cohen
Vice President and Global Head of Functional
Genomics, Novartis Pharmaceuticals, USA
|
| 12.15 - 13.00
hrs
|
(IL
– 2)
|
"From
genome to systems to targets: the path with yeast"
Dr. Steve Oliver
Professor of Genomics,
Faculty of Life Sciences
University of Manchester, United Kingdom |
| 13.00
– 14.00 hrs
|
|
Lunch |
| 14.00 - 14.45
hrs
|
(IL
–3)
|
"Coordinating
roles of PPARs in energy homeostasis and tissue repair"
Dr. Walter Wahli
Professor and Director
Center for Integrative Genomics
University of Lausanne, Switzerland |
| 14.45 - 15.30
hrs
|
(IL
–4)
|
“Basic molecular
biology of nuclear steroid receptors”
Dr. Shigeaki Kato
Professor
Institute of Molecular and Cellular Biosciences,
University of Tokyo, Japan |
| 15.30
- 17.00 hrs
|
|
Tea Break & Poster Session |
| 17.00 - 17.45
hrs
|
(IL
–5)
|
“Peptides
for treatment of benign and malignant tumors”
Prof. Dr. Juergen Engel
Chairman and Managing Director
Zentaris GmbH, Germany |
| 17.45
- 18.30 hrs
|
(IL
–6)
|
“Mapping
the human kineome and phosphoproteome with antibody and peptide
probes”
Prof. Steven Pelech, Ph.D.
Professor, The Brain Research Centre, University of British Columbia,
Canada
President & CSO, Kinexus Bioinformatics Corporation, Canada
|
| 19.00
hrs Onwards
|
|
Dinner
& Cultural Program |
| Day
II : Monday : January 24, 2005 |
| 08.30
- 09.30 hrs
|
Key-Note
Address
(PL-2)
|
"Intrinsically Unfolded
Proteins: What is their Possible Biological Role?"
Prof. Joel L. Sussman
The Morton and Gladys Pickman Professor of Structural Biology
Weizmann
Institute of Science, Israel |
| 09.30
- 10.15 hrs
|
(IL
–7)
|
"Peptide Toxin from Indian Cone Snails
: Revisiting the Chemistry & Biology of Natural Products "
Prof. P. Balaram
Molecular Biophysics Unit
Indian Institute of Science, India
|
| 10.15
- 10.45 hrs
|
|
Tea
Break |
| 10.45
- 11.30 hrs
|
(IL
–8)
|
“Channelling mechanism
as revealed from the crystal structure of a fatty acid b-oxidation
multienzyme complex”
Prof. Kosuke Morikawa
Director, Biomolecular Engineering Research Institute
Osaka, Japan |
| 11.30
- 12.15 hrs
|
(IL
–9)
|
"The
Application of Proteomics Technologies in Pharmaceutical Industry"
Dr. Hanno Langen
Head of Proteomics Initiative, Roche Center for Medical Genomics,
Hoffmann-La Roche, Switzerland |
| 12.15
- 13.00 hrs
|
(IL –10)
|
"Comparative
proteomics In slico for drug target indentification"
Dr. Samir K. Brahmachari
Institute of Genomics & Integrative
Biology, India |
| 13.30
- 13.45 hrs
|
(IL –11)
|
“
Application of an Integrated Biological and Chemical Genomics Platform
for Identification and Validation of Drug Targets”
Dr. Deepika Madan
Director Automation
ALTANA Research Institute, USA |
| 13.45 - 15.30 hrs |
|
Lunch & Posters |
| 15.30
- 18.00 hrs
|
|
Visit to Zydus
Facilities/Ahmedabad City Tour |
| 19.00
hrs Onwards
|
|
Cultural program
of Zydus Research Centre & Dinner |
| Day
III : Tuesday : January 25, 2005 |
| 09.00
- 10.00 hrs
|
Key-Note
Address
(PL-3)
|
"Proteomics Approaches
to Diagnosis and Treatment Monitoring of Cancers"
Gilbert S. Omenn, M.D., Ph.D.
Executive Vice President for Medical Affairs
CEO for University of Michigan Health System
Professor of Internal Medicine
Professor of Human Genetics
University of Michigan, USA |
| 10.00
- 10.45 hrs
|
(IL
–12)
|
“Genomic technologies
to detect drug activities and potential liabilities"
Dr. Mark Cockett
Vice-President, Applied Genomics
Bristol-Myers Squibb, USA |
| 10.45
- 11.15 hrs
|
|
Tea
Break |
| 11.15
- 12.00 hrs
|
(IL
–13)
|
“Production
of a Allelic Series of the Mouse Dishevelled 2 Gene: Determination
of Developmental Pathways and Mechanisms Important for Neural Tube
Closure”
Dr. Tony Wynshaw-Boris
Professor, Departments of Pediatrics and Medicine
Director, Center for Human Genetics and Genomics
Chief, Division of Genetics, Department of Pediatrics
Univ of California, San Diego, USA |
| 12.00
- 12.45 hrs
|
(IL –14)
|
“Genetics
on Embryonic Stem cells; closing the gap between yeast and mouse”
Dr. Andras Nagy
Professor
Department of Medical Genetics & Microbiology
University of Toronto, Canada |
| 12.45
- 13.30 hrs
|
(IL –15)
|
"Design
and Application of Synthetic Antibodies"
Dr. Sachdev
Sidhu
Senior Scientist
Department of Protein Engineering
Genentech, USA |
| 13.30 - 14.30 hrs
|
|
Lunch |
| 14.30
- 15.15 hrs
|
(IL
–16)
|
“Conformationally-constrained
Oxetane Modified Antisense Oligonucleotides Function Efficiently as
Novel Gene Silencing Molecules "
Dr. Jyoti Chattopadhyay
Professor & Chairman
Department of Bioorganic Chemistry
Uppsala University, Sweden |
| 15.15
- 16.00 hrs
|
(IL
–17)
|
“Nucleic
Acid Based Therapeutics for Treating Human Malignancies”
Dr Alan M. Gewirtz
Doris Duke Distinguished Clinical Professor,
Medicine and Pathology.
Leader, Stem Cell Biology & Therapeutics Program,
University of Pennsylvania School of Medicine, USA |
| 16.00
- 16.30 hrs |
|
Tea
Break |
| 16.30 - 17.15 hrs |
(IL
–18)
|
“Pharmacogenetics
of hypertension”
Prof. G Neil
THOMAS
Research Assistant Professor
Department of Community Medicine,
University of Hong
Kong |
| 17.15 - 18.00 hrs |
(IL
–19)
|
“Identifying and
validating biomarkers that bridge the preclinical and clinical”
Dr Pauline Gee
Vice-President, Predictive Biology
MDS Pharma, UK |
| 18.00
- 19.00 hrs |
|
Panel
Dicussion & Closing Ceremony |
|
